The efficacy of nutrition and lifestyle approaches in the treatment of depression

Topics in Clinical Nutrition

Volumn 24, Issue 1, 2009, Pages 55-66

  Truesdell, Delores D ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

B vitamins; Depression; Folic acid; Mood disorder; Omega 3 fatty acids; Vitamin B12 cobalamin; Vitamin B6; Vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; CALCITRIOL; COLECALCIFEROL; CYANOCOBALAMIN; CYCLOSPORIN; DIGOXIN; DOCOSAHEXAENOIC ACID; ESTROGEN; FLUOXETINE; FOLIC ACID; FOLIC ACID DERIVATIVE; HOMOCYSTEINE; HYPERICUM PERFORATUM EXTRACT; ICOSAPENTAENOIC ACID; INDINAVIR; METHOTREXATE; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PLACEBO; PROLACTIN; PROTON PUMP INHIBITOR; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SULFONAMIDE; THEOPHYLLINE; VERAPAMIL; VITAMIN D; WARFARIN;

ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATAXIA; BECK DEPRESSION INVENTORY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CYANOCOBALAMIN DEFICIENCY; DEPRESSION; DIARRHEA; DIET; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DROWSINESS; DRUG COST; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; FATIGUE; FLUSHING; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GASTROINTESTINAL SYMPTOM; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HAMILTON SCALE; HUMAN; INSOMNIA; IRRITABILITY; LIFESTYLE MODIFICATION; MAJOR DEPRESSION; MALAISE; MANIA; MONOTHERAPY; NAUSEA; NEPHROLITHIASIS; NEPHROTOXICITY; NEUROTOXICITY; NUTRITION EDUCATION; OUTPATIENT CARE; PARESTHESIA; PHOTOSENSITIVITY; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SCREENING TEST; SENSORY NEUROPATHY; SIDE EFFECT; SKIN ALLERGY; SKIN TOXICITY; SUN EXPOSURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; XEROSTOMIA;

EID: 68549125307     PISSN: 08835691     EISSN: None     Source Type: Journal    
DOI: 10.1097/TIN.0b013e31819898ff     Document Type: Review

References (68)

1. Morley J. Editorial: hot topics in geriatrics. J Gerontol. 2003;58A:30-36.
2. Anderson RJ, Clouse RE, Freedland KE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. A meta-analysis. Diabetes Care. 2001;24:1069-1078.
3. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003;54:283-294.
4. Dunlop DD, Manheim LM, Song J, Lyons JS, Chang RW. Incidence of disability among preretirement adults: the impact of depression. Am J Public Health. 2005;95:2003-2008. http://www.ajph.org/cgi/ content/full/95/11/2003. Accessed March 16, 2008.
5. Kerse N, Flicker L, Pfaff JJ, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One. 2008;3(6):e2423. http://www. plosone.org/doi/pone.0002423. Accessed June 18, 2008.
6. Merck. Depressive disorders. http://www.merck. com/mmpe/sec15/ch200/ ch200b.html. Accessed March 14, 2008.
7. Bhatia SC, Bhatia SK. Depression in women: diagnostic and treatment considerations. Am Fam Physician. 1999;60:225-240.
8. Bjerkeset O, Romundstad P, Evans J, Gunnell D. Association of adult body mass index and height with anxiety, depression, and suicide in the general population: the HUNT study. Am J Epidemiol. 2008;167:193-202.
9. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163:2141-2147. http://ajp. psychiatryonline.org/cgi/content/full/163/12/2141. Accessed March 17, 2008.
10. Adams SM, Miller KE, Zylstra RG. Pharmacologic managementof adult depression. Am Fam Physician .2008;77:785-792, 795-796.
11. Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of progressive resistance training in depressed elders. J Gerontol Ser A: Biol Sci Med Sci. 1997;52:M27-M35.
12. Knubben K, Reischies FM, Adli M, Schlattmann P, Bauer M, Dimeo F. A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression. Br J Sports Med. 2007;41:29-33.
13. Cheung CK, Wyman JF, Halcon LL. Use of complementary and alternative therapies in community-dwelling older adults. J Altern Complement Med. 2007;9:997-1006.
14. Werneke U. Complementary medicines in psychiatry. Br J Psychiatry. 2006;188:109-121.
15. Folstein M, Liu T, Peter I, et al. The homocysteine hypothesis of depression. Am J Psychiatry. 2007;164(6):861-867.
16. Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B-12. J Psychopharmacol. 2005;19:59-65.
17. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. Can Med Assoc J. 2004; 171:897-904.
18. Tolmunen T, Voutilanienen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr. 2003;133:3233-3236.
19. Sachdev PS, Parslow RA, Lux O, et al. Relationship of homocysteine, folic acid and vitamin B-12 with depression in middle-aged community sample. Psychol Med. 2005;35:529-538.
20. Reynolds EH, Preece JM, Bailey J, Coppen A. Folic acid, aging, depression and dementia. Br J Psychiatry. 1970;117:287-292.
21. Gilbody S, Lightfoot T, Sheldon S. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health. 2007;61:631-637. http://jech.bmj.com/cgi/ content/abstract/61/7/631. Accessed March 18, 2008.
22. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydro-folate reductase (MTHFR) genetic polymorphisms and psychiatric disorders. A HuGE review. Am J Epidemiol. 2007;165:1-13.
23. Godfrey PS, Toone BK, Carney MW, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336:953-954.
24. McMahon JA, Green TJ, Skeaff M, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354:2704-2772.
25. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr. 2002;75:908-913.
26. Selhub J, Bagley L, Miller J, Rosenber I. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71:614S-620S.
27. Calvaresi E, Bryan J. B vitamins, cognition and gaining: a review. J Gerontol. 2001;56B:P327-P339.
28. Coppen A, Bailey J. Enhancement of the antide-pressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord. 2000;60:121-123.
29. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglier T. Folate, vitamin B-12, and homocysteine in major depressive disorder. Am J Psychiatry. 1997;154:426-428.
30. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J. 2006;151(2):282-287.
31. Pfeiffer C, Caudill S, Gunter E, et al. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-450.
32. Ray J, Vermeulen M, Langman L, et al. Persistence of vitamin B12 insufficiency among elderly women after folic acid food fortification. Clin Biochem. 2003;36:387-391.
33. Pronsky Z. Food Medication Interactions. 15th ed. Birchrunville, PA: Food Medication Interactions. www.foodmedinteractions.com. Accessed January 6, 2008.
34. University of California Cooperative Extension. Is Saint John's wort a safe and effective antidepressant? Nutr Perspect. 2002;27(2). http://nutrition.ucdavis. edu/perspectives/MarApr02.html. Accessed July 2, 2008.
35. Ernst E. Commentary. Second thoughts about safety of St. John's wort. Lancet. 1999;354:2014-2016.
36. Taylor MJ, Carney SM, Goodwin GM, Geddes JR. Fo-late for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol. 2004;18:251-256.
37. Williams E, Stewart-Knox B, Bradbury I, et al. Effect of folic acid supplementation on mood and serotonin response in healthy males. Br J Nutr. 2005;94:602-608.
38. Bazzano LA, Reynolds K, Holder KN, He JH. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296:2720-2726.
39. Maalouf R, Grimley EJ. The effect of vitamin B-6 on cognition. Cochrane Database Syst Rev. 2003;(4):CD004393.
40. Havas AM, Bech JS, Nexo E. Vitamin B-6 level is associated with symptoms of depression. Psychother Psychosom. 2004;73:340-343.
41. Williams AL, Cotter A, Sabrina A, Girovol C, Goodman J, Katz DL. The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract. 2005;22:532-537.
42. Dimopoulos N, Piperi C, Salonicioti A, et al. Correlation of folate, vitamin B-12 and homocysteine levels with depression in an elderly Greek population. Clin Biochem. 2007;40:604-608.
43. Clement L, Boylan M, Miller VG, Rockwell M, Allred K. Serum levels of folate and cobalamin are lower in depressed than in nondepressed hemodialysis subjects. J Renal Nutr. 2007;17:343-349.
44. Tiemeier H, Van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B-12, folate and homocys-teine in depression: the Rotterdam study. Am J Psychiatry. 2002;159:2099-2101.
45. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003;88:185-191.
46. 3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8. http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=506781. Accessed May 15, 2007.
47. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14:1032-1040.
48. Aloia J, Patel M, DiMaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008;87:1952-1958.
49. Barclay L. Low levels of serum 25 (OH) D linked with depression in elderly patients. Arch Gen Psychiatry. 2008;65:508-512.
50. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006;163(6):969-978.
51. Hakkarainen R, Partonen T, Haukka J, et al. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry. 2004;161(3):567-569.
52. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trials. Prostaglandins Leukotr Essent Fatty Acids. 2003;69(6):477-485. http://www.ncbi.nlm.nih.gov/pubmed/14623502. Accessed April 6, 2008.
53. Osher Y, Belmaker RH. Clinical trials of PUFAs in depression: state of the art. World J Biol. 2006;7(4):223-230.
54. Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med. 2006;42(1):4-13.
55. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007;12:331-359.
56. Nemets B, Stahl Z, Belmaker R. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477-479.
57. Feart C, Peuchant E, Letenneur L, et al. Plasma eicos-apentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly; data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr. 2008;87:1156-1162.
58. Akabas S, Deckelbaum R. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am J Clin Nutr. 2006;83:1536S-1538S.
59. Hibbeln J, Nieminen L, Blasbalg T, et al. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006;83:1483S-1493S.
60. Merck. Fish oil. In: The Merck Manual of Diagnosis and Therapy. Whitehouse Station, NJ: Merck. http:// www.merck.com/mmpe/sec22/ch331/ch331k. html. Published 2005. Accessed November 25, 2008.
61. American Dietetic Association. Pocket Guide for International Dietetics & Nutrition Terminology Reference Manual. Standardized Language for the Nutrition Care Process. Chicago, IL: American Dietetic Association; 2008.
62. Gilbody S, House AO, Sheldon TA. Screening and case finding instruments for depression. Cochrane Database Syst Rev. 2005;(4):CD002792. doi:10.1002/14651858.CD002792.pub2.
63. American Dietetic Association. American Dietetic Association Evidence Analysis Library. http://www. adaevidencelibrary.com. Accessed March 12, 2008.
64. US DepartmentofHealth and Human Services and US Department of Agriculture. Dietary Guidelines for Americans. 6th ed. Washington, DC: US Government Printing Office; 2005.
65. Sullivan DH, Sun S, Walls R. Protein-energy un-dernutrition among elderly hospitalized patients. A prospective study. JAMA. 1999;281:2013-2019.
66. Sarkisian CA, Lachs MS. "Failure to thrive" in older adults. Ann Intern Med. 1996;124:1072-1078. http://www.annals.org/cgi/content/ full/124/12/1072. Accessed April 1, 2008.
67. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:161, 162, 168.
68. McCurren C. Assessment for depression among nursing home elders: evaluation of the MDS Mood Assessment. Geriatr Nurs. 2002:23:103-108.